tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market

Aptevo Therapeutics (APVO) Income Statement

Compare
491 Followers

Aptevo Therapeutics Income Statement

Last quarter (Q3 2024), Aptevo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aptevo Therapeutics's net income was $-5.10M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 3.11M$ 12.29M$ 4.31M
Gross Profit
$ 0.00$ -567.00K$ 2.21M$ -6.70M$ -13.54M
Operating Expenses
$ 24.60M$ 28.88M$ 31.75M$ 33.69M$ 31.80M
Depreciation and Amortization
$ 0.00$ 567.00K$ 901.00K$ 1.14M$ 1.41M
EBITDA
$ -24.60M$ -28.31M$ -27.74M$ -20.26M$ -26.09M
Operating Income
$ -24.60M$ -28.88M$ -28.64M$ -21.40M$ -27.49M
Other Income/Expenses
$ 472.00K$ 10.23M$ 35.66M$ -8.01M$ -3.43M
Pretax Income
$ -24.13M$ -18.65M$ 7.01M$ -29.41M$ -30.92M
Net Income
$ -24.13M$ -17.41M$ 42.67M$ -27.31M$ -18.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -84.67$ -2.32K$ 366.71$ -256.35$ -239.38
Diluted EPS
$ -84.67$ -2.32K$ 367.92$ -256.35$ -239.38
Weighted Average Shares Outstanding
285.00K- 116.36K 106.54K 77.07K
Weighted Average Shares Outstanding (Diluted)
285.00K- 115.97K 106.54K 77.07K
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis